News
RMD
219.68
+3.65%
7.74
ResMed Likely to Start Raising Prices in December Quarter -- Market Talk
Dow Jones · 14h ago
Ord Minnett Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 18h ago
Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 19h ago
*ResMed Price Target Cut 0.9% to $227.00/Share by Morgan Stanley
Dow Jones · 19h ago
Citi Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 20h ago
*ResMed Price Target Raised 0.4% to A$46.80/Share by Macquarie
Dow Jones · 20h ago
Here's What Analysts Are Forecasting For ResMed Inc. (NYSE:RMD) After Its Full-Year Results
Simply Wall St · 1d ago
Top 50 High-Quality Dividend Growth Stocks For August 2026
Seeking Alpha · 1d ago
ResMed Inc Balances Astral Hit With Robust Core Growth
TipRanks · 1d ago
Oppenheimer Issues a Hold Rating on Resmed (RMD)
TipRanks · 2d ago
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from UBS
TipRanks · 2d ago
ResMed (RMD) Stock Drops As Margin Strength Meets Higher Expectations
Simply Wall St · 2d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of August 9
Seeking Alpha · 2d ago
ResMed Inc. Stock Falls 5.1%, Underperforms Market
Dow Jones · 2d ago
ResMed Is Maintained at Sector Perform by RBC Capital
Dow Jones · 2d ago
RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244
Benzinga · 2d ago
JS&P 500 Hits Record As Jobs Shock Sinks Rate-Hike Bets: Stock Market Today
Benzinga · 3d ago
ResMed Is Maintained at Neutral by Piper Sandler
Dow Jones · 3d ago
ResMed Price Target Cut to $225.00/Share From $233.00 by Piper Sandler
Dow Jones · 3d ago
Piper Sandler Maintains Neutral on ResMed, Lowers Price Target to $225
Benzinga · 3d ago
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.